메뉴 건너뛰기




Volumn 16, Issue 14, 2015, Pages 2017-2022

Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry

Author keywords

CFTR correctors; click chemistry; cystic fibrosis; protein expression; VX 809

Indexed keywords

ALK 809; ALKYNE DERIVATIVE; COPPER; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; LUMACAFTOR; SUL 809; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; AMINOPYRIDINE DERIVATIVE; PROTEIN BINDING;

EID: 84941749089     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201500123     Document Type: Article
Times cited : (22)

References (31)
  • 15
    • 84859884931 scopus 로고    scopus 로고
    • Z. Corbyn, Lancet 2012, 379, 1475-1476;
    • (2012) Lancet , vol.379 , pp. 1475-1476
    • Corbyn, Z.1
  • 26
    • 84941735063 scopus 로고    scopus 로고
    • FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation" Vertex Pharmaceuticals Inc., 2015.
    • "FDA Approves ORKAMBI™ (lumacaftor/ivacaftor)-the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation" Vertex Pharmaceuticals Inc., http://investors.vrtx.com/releasedetail.cfm?ReleaseID=920512, 2015.
  • 28
  • 30
    • 84855677550 scopus 로고    scopus 로고
    • Angew. Chem. 2011, 123, 8201-8206.
    • (2011) Angew. Chem. , vol.123 , pp. 8201-8206


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.